Indian Cabinet Ministers In Stalemate Over New Pharma Policy
This article was originally published in PharmAsia News
Three Indian Cabinet ministers responsible for reaching a compromise on the country's drug policy are stalemated. The health and chemicals ministries, led by the agriculture minister, were assigned to sort out the policy. The health ministry wants quality control and drug supplies to be excluded from the policy. The chemicals ministry, which has administrative authority over pharmas, drafted the policy, but quality regulation and marketing approvals are under the purview of the health ministry. The agriculture minister told both sides to work out their differences. (Click here for more
You may also be interested in...
Abbott reported third-quarter 2020 global sales of $8.9bn, driven by its strong position in COVID-19 tests. See what Abbott’s CEO Robert Ford said about it here.
With the threat of potentially hefty fines, China's newly passed Biosecurity Law will fundamentally change how the life science sector handles human genetic resources over years to come, legal experts say.
Ahead of the vaccine advisory committee, requests to FDA range from public health groups opposing emergency use authorizations to industry seeking labeling guidance on EUA products.